Research map: Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases
Back to the article
Papers in this map
Staging of brain pathology related to sporadic Parkinson’s disease
· Heiko Braak · 2002 · 10997 citations · Cited by this paper
Endogenous neuroprotection in vascular cognitive impairment and dementia
· 2026 · Related
MDS clinical diagnostic criteria for Parkinson's disease
· Ronald B. Postuma · 2015 · 7781 citations · Cited by this paper
Chronological versus physiological age for 10-year survival estimation: a real-world healthsystem-wide cohort analysis
· 2026 · Related
The Neuropsychiatric Inventory
· Jeffrey L. Cummings · 1994 · 7641 citations · Cited by this paper
Microcephaly-like phenotype triggered by novel reassortant and prototypic Oropouche virus strains in brain organoids
· 2026 · Related
Diagnosis and management of dementia with Lewy bodies
· Ian Grant McKeith · 2005 · 5143 citations · Cited by this paper
Immunology of pregnancy and sepsis: shared and specific pathways guiding future precision care
· 2026 · Related
Diagnosis and management of dementia with Lewy bodies
· Ian Grant McKeith · 2017 · 4583 citations · Cited by this paper
CardioMorph Atlas: a statistical approach to evaluate association between pulmonary tuberculosis and cardiac morphology from chest X-rays
· 2026 · Related
Parkinson disease-associated cognitive impairment
· Dag Aarsland · 2021 · 1421 citations · Cited by this paper
d-serine as a metabolic immune checkpoint in the tumour microenvironment
· 2026 · Related
Selective neuronal vulnerability in Parkinson disease
· Dalton James Surmeier · 2017 · 1186 citations · Cited by this paper
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms
· 2026 · Related
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
· Ronald B. Postuma · 2019 · 1143 citations · Cited by this paper
Intratumoural plasma cells mediate a pro-inflammatory response to kinase inhibition and successful immune checkpoint blockade therapy in malignant peripheral nerve sheath tumours
· 2026 · Related
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
· the Alzheimer’s Disease Neuroimaging Initiative · 2021 · 782 citations · Cited by this paper
Determinants of the plasma metabolome: cross-sectional and longitudinal associations over six years in the NESDA cohort
· 2026 · Related
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
· Thomas G. Beach · 2009 · 718 citations · Cited by this paper
Tumour cell density quantified by artificial intelligence is associated with differential benefit from irinotecan-based chemo-radiotherapy in locally advanced rectal cancer: a post-hoc study of the phase 3 ARISTOTLE trial
· 2026 · Related
Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression
· Seyed‐Mohammad Fereshtehnejad · 2017 · 634 citations · Cited by this paper
Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe
· Adam J. Harding · 2002 · 618 citations · Cited by this paper
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference
· Alexandra L. Young · 2018 · 618 citations · Cited by this paper
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
· David John Irwin · 2016 · 609 citations · Cited by this paper
Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline
· Lani Kai Clinton · 2010 · 589 citations · Cited by this paper
Idiopathic REM sleep behaviour disorder and neurodegeneration — an update
· Birgit Högl · 2017 · 559 citations · Cited by this paper
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
· Daniela Berg · 2014 · 510 citations · Cited by this paper
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
· Nicolas Giguère · 2018 · 448 citations · Cited by this paper
Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations
· Daniel Collerton · 2005 · 447 citations · Cited by this paper
The progression of pathology in longitudinally followed patients with Parkinson’s disease
· Glenda Margaret Halliday · 2008 · 430 citations · Cited by this paper
Dementia with Lewy bodies: an update and outlook
· Tiago F. Outeiro · 2019 · 392 citations · Cited by this paper
Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease
· Jennifer L. Whitwell · 2007 · 353 citations · Cited by this paper
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study
· Elijah E Mak · 2015 · 266 citations · Cited by this paper
Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment
· A Bruck · 2004 · 252 citations · Cited by this paper
Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?
· James M. Shine · 2011 · 215 citations · Cited by this paper
Patterns of Cerebral Atrophy in Dementia with Lewy Bodies Using Voxel-Based Morphometry
· Emma J. Burton · 2002 · 214 citations · Cited by this paper
Neuroanatomical correlates of impaired decision‐making and facial emotion recognition in early Parkinson’s disease
· Naroa Ibarretxe‐Bilbao · 2009 · 202 citations · Cited by this paper
Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies
· Zuzana Nedelská · 2014 · 157 citations · Cited by this paper
Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease
· Michail E. Kalaitzakis · 2008 · 146 citations · Cited by this paper
Source: OpenAlex (CC0)